To study which drug is better whether Gambhariphal granules or Ashwagandha granules in the management of karshya (Underweight children).

A randomized controlled clinical study of Gambhariphal granules and Ashwagandha granules in the management of karshya(underweight) in children of age group between 6-12 years. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061826

Enrollment

Registered

2024-01-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E43- Unspecified severe protein-caloriemalnutrition

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Weight less than 80 percent for age Patients having clinical features like Daurbalya,Aruchi,kshudhaprachiti, Sthoolparva Children of age group between 6-12 years irrespective of the sex

Exclusion criteria

Exclusion criteria: K/C/O Grahani Dosha K/C/O systemic disorder like Carcinoma, Hepatitis,HIV, Tuberculosis K/C/O Inborn Error of Metabolism K/C/O endocrinal disorder like hyperthyroidism ,food allergy

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Gambhariphal granules for 60 days in the management of Karshya on the basis of their symptoms like Daurbalya,Aruchi etc.Timepoint: 60 days where follow up on 15th,30th,45th,60th day	—

Secondary

Measure	Time frame
To Observe the adverse effects if anyTimepoint: 60 days where follow up on 15th,30th,45th,60th day	—

Countries

India

Contacts

Public ContactDr Madhavi Deodas

PDEAS college of Ayurveda and Research centre Nigdi

drdeodasms@gmail.com9423010818

Outcome results